Canine retinal arterial and arteriolar dilatation induced by nipradilol, a possible glaucoma therapeutic

Pharmacology

Volumn 53, Issue 5, 1996, Pages 302-310

  Okamura, Tornio ^a   Kitamura, Yoshihiko ^a   Uchiyama, Masami ^a   Toda, Megumi ^a   Ayajiki, Kazuhide ^a   Toda, Noboru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Nipradilol; Nitric oxide; Retinal arteriole; Retinal central artery; Vasodilatation

Indexed keywords

ANTIGLAUCOMA AGENT; ARGININE DERIVATIVE; CYCLIC GMP; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; INDOMETACIN; ISOPRENALINE; METHYLENE BLUE; NIPRADILOL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; OXYHEMOGLOBIN; PROSTAGLANDIN F2 ALPHA; TIMOLOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY DILATATION; ARTERY MUSCLE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG POTENCY; ENZYME ACTIVATION; EYE FUNDUS; FEMALE; GLAUCOMA; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RETINA ARTERY; SMOOTH MUSCLE RELAXATION;

EID: 0029804049     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139443     Document Type: Article

References (24)

1. Nathanson JA: Nitrovasodilators as a new class of ocular hypotensive agents. J Pharmacol Exp Titer 1992: 260:956-965.
2. Schuman JS, Erickson K, Nathanson JA: Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys. Exp Eye Res 1994;58:99-105.
3. Chiou GCY, Liu SXL, Li BHP, Chiang CH, Varma RS: Ocular hypotensive effects of α.-arginine and its derivatives and their actions on ocular blood flow. J Ocul Pharmacol 1995;11:1-10.
4. Chiou GCY. Chen YJ: Effects of antiglaucoma drugs on ocular blood flow' in ocular hypertensive rabbits. J Ocul Pharmacol 1993:9:13-24.
5. Araki H. Hayata N, Nakamura M: Effects of nipradilol, a new betablocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: A double-blind study. Clin Ther 1987: 9:656-662.
6. Kishida H. Saito T. Nejima J. Mala N, Kusama Y, Suzuki T, Otsu F. Kaneko H. Inokuchi N: Evaluation of a new antiangina! agent, nipradilol, in effort angina using Holtcr monitoring. Jpn Heart J 1988:29: 309-317.
7. Uchida Y, Nakamura M. Shimizu S. Shirasawa Y. Fujii M: Vasoactive and 1-adrcnoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-ni-troxy-2H-l-benzopyran (K-351). a new antihypertensive agent. Arch Pharmacodyn Thcr 1983:262:132-149.
8. Sasage H. Nakazawa M. Arakawa M. Imai S: Contribution of cyclic GMP generation to the relaxation by nipradilol in the rabbit aorta. Gen Pharmacol 1995;26:85-91.
9. Uchida Y: Cardiovascular effect of 3,4-dihvdro-8-(2-hydroxy-3-isopro-pylaminopropoxy)-3-nitroxy-2H-1-benzopvran (K-351). Jpn Heart J 1982;23:981-988.
10. Araic M. Ohshika T, Aihara M. Masuda K, Ando Y, Yamamoto T, Kitazawa Y. Sawanobori K. Go Y: New possible ocular hypotensive drugs developed in Japan (in Japanese). J Eye 1994:1 (suppl 1):51-58.
11. Kitamura Y, Okamura T, Kani K. Toda N: Nitric oxide-mediated retinal arteriolar and arterial dilatation induced by substance P. Invest Ophthalmol Vis Sci 1993:34:2859-2865.
12. Martin W, Villani GM, Jothianan-dan D. Furchgott RF: Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Thcr 1985:232:708-716.
13. Miyazaki M. Yamamoto M, Toda N: interaction between non-steroidal anti-inflammatory agents and sodium salicylate in the relaxant response of dog renal arteries to angiotensin II. Arch Int Pharmacodyn Ther 1985:274:210-222.
14. Toda N, Ayajiki K. Yoshida K, Ki-mura H. Okamura T: Impairment by damage of the pterygopalatine ganglion of nitroxidergic vasodilator nerve function in canine cerebral and retinal arteries. Circ Res 1993: 72:206-213.
15. Toda N. Okamura T: Role of nitric oxide in ncurallv induced ccrebroar-terial relaxation. J Pharmacol Exp Ther 1991;258:1027-1032.
16. Toda N, Kitamura Y. Okamura T: Role of nitroxidergic nerve in dog retinal arterioles in vivo and arteries in vitro. Am J Physiol 1994:266: H1985-H1992.
17. Kabuto S, Kimata H, Yonemitsu M. Suzuki J: Metabolism of nipraditol by liver homogenates from different species. 1. Comparative studies on the denitration of nipradilol and other organic nitrates. Xcnobiotica 1986;16:307-315.
18. Donati G. Pournaras CJ. Munoz JL. Poitry S. Poitry-Yamate CL. Tsaco-poulos M: Nitric oxide controls arteriolar tone in the retina of the miniature pig. Invest Ophthalmol Vis Sci 1995;36:2228-2237.
19. Toda N: The action of vasodilating drugs on isolated basilar, coronary and mesenteric arteries of the dog. J Pharmacol Exp Ther 1974; 191:139-146.
20. Toda N. Okamura T, Miyazaki M: Age-dependent changes in the response of isolated beagle coronary' arteries to transmural electrical stimulation and catecholamines. J Pharmacol ExpTher 1986;238:319-326.
21. Novack GD: Ophthalmic beta-blockers since timolol. Surv Ophthalmol 1987:31:307-327.
22. Vareilles P. Lotti VJ: Effect of timolol on aqueous humor dynamics in the rabbit. Ophthalmic Res 1981; 13:72-79.
23. Lcsar TS: Comparison of pharmacokinetic properties of beta-adrenoceptor blocking agents. Clin Pharm 1987:6:451-463.
24. Kou K. Ibcngwe J. Suzuki H: Effects of alpha-adrenoceptor antagonists on electrical and mechanical responses of the isolated dog mesenteric vein to perivascular nerve stimulation and exogenous noradrenaline. Naunyn Schmiedeberg’s Arch Pharmacol 1984;326:7-13.